Based in Charlotte, NC, SonaCare Medical designs and manufactures HIFU (high intensity focused ultrasound) surgical ablation systems that offer physicians and patients both clinical effectiveness and quality-of-life interventions. SonaCare Medical’s strategic vision is to develop and commercialize a range of products aimed at bringing the benefits of therapeutic focused ultrasound to as many patients as possible.
The company’s Sonasource® device is the first focused ultrasound device to be FDA cleared for the ablation of prostate tissue. This platform delivers ablative ultrasound in a way that maximizes opportunities for an institution or facility to amortize the cost of an energy-based system across multiple clinical conditions, target organ systems, and medical specialties.
The Sonasource platform has been designed and has received regulatory authorization to be used with multiple probes and ablation delivery devices, including their Sonablate® and Sonatherm® probes that are currently being used for prostate and kidney conditions.
MellingMedical is proud to offer Sonacare’s innovative technology to the DEPARTMENT OF VETERANS AFFAIRS through our Contract Number V797D-50471. The current Contract Period runs November 15, 2015 to November 14, 2020
Federal Supply Service
Medical Equipment and Supplies FSC Group 65 FSC Classes: 6510, 6515, 6530, 6532, 6540, 6545, J065 Primary NAICS: 339112
Click here to view: MellingMedical‘s Authorized Federal Supply Schedule Price List